Search

everythinglearnresearchcommunity

for

Search:↓

The new treatment regimen was effective in promoting significant hair growth in all 15 male patients with androgenic alopecia.

The anti-viral drug Elvitegravir may protect brain cells from damage related to neurodegenerative diseases.

Finasteride increases hair count and improves hair growth with low risk of side effects.

Plant-based chemicals may help hair growth and prevent hair loss but need more research to compete with current treatments.

Androgenetic alopecia linked to COVID-19 severity; drugs reducing androgen receptor activation may help.

Severe male balding may increase the risk of serious COVID-19, and treatments that reduce androgens or block a specific enzyme might help protect these individuals.

Large prostates link to more hair loss.

Men's sensitivity to male hormones might affect how severe COVID-19 gets for them.

5-Alpha-Reductase inhibitors shorten COVID-19 recovery time in men.

Frontal fibrosing alopecia may affect nails and could be a type of lichen planus, treatable with certain medications.

Older patients sticking to their prostate medication saw lasting health benefits.

Natural products and phytochemicals may help with hair regrowth, but more research is needed.

Hormones like androgens, estrogen, thyroid hormones, and stress hormones can contribute to hair loss, and treatments target these hormonal imbalances.

Afatinib, neratinib, and zanubrutinib could be effective against KRASG12C-mutant tumors.

Bioengineered nanoparticles can effectively treat hair loss by targeting specific enzymes and receptors.

Most COVID-19 patients in hospitals have androgenetic alopecia, more in men, suggesting a link between androgen sensitivity and severe COVID-19 symptoms.

Men taking 5-alpha reductase inhibitors for prostate issues may be less likely to experience severe COVID-19, but it doesn't prevent ICU admission or death.

Men on 5-alpha-reductase inhibitors might have worse COVID-19 outcomes.

A new microneedle patch treats hair loss effectively with fewer side effects and less frequent use.

Diphenylcyclopropenone treatment helps prevent hair loss relapse in alopecia areata patients.

Hormone treatment for transgender patients may not need to be stopped before surgery, but more research is needed, especially on estrogen.

Sex hormones may affect COVID-19 severity, with men often faring worse, and targeting related pathways could offer treatment options.

Unroofing is an effective, less invasive, and cost-effective surgery for hidradenitis suppurativa with low recurrence and improved patient quality of life.

Hair loss drugs may cause sexual issues and infertility in men.

Many products for hair re-growth exist, but a perfect treatment without side effects has not yet been found.

Hair loss improved after removing pituitary tumor.

Male pattern hair loss could hint at androgens affecting COVID-19 severity.

Genetic differences may affect COVID-19 deaths; anti-androgens could be potential treatment.

Herbs can potentially treat hair loss by inhibiting a key enzyme and promoting hair growth, and deficiencies in zinc, biotin, and iron are linked to hair loss.

5-alpha-reductase inhibitors may reduce COVID-19 symptoms in bald males.